Kairos Pharma, Ltd. (KAPA) AMEX
0.63
+0.0104(+1.68%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.63
+0.0104(+1.68%)
Currency In USD
| Market Cap | 17.26M |
| Enterprise Value | 15.99M |
| P/E Ratio | -2.51 |
| PEG Ratio | -0.28 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.66 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.57 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.63 |
| Return On Equity | -0.79 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -160,000 |
| EBITDA | -1.58M |
| Net Income | -2.6M |
| Diluted EPS | -0.23 |
| Total Cash | 5.58M |
| Total Cash/Share | 0.28 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 16.56 |
| Book Value Per Share | 0.38 |
| 52-Week Change | -33.89 |
| 52-Week High | 2.11 |
| 52-Week Low | 0.4 |
| Moving Average 50 Days | 0.67 |
| Moving Average 200 Days | 0.9 |
| Average Volume | 557,330 |
| Shares Outstanding | 20.74M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |